Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants

Deidre Wilkins; Yuan Yuan; Yue Chang; Anastasia A. Aksyuk; Beatriz Seoane Núñez

doi:10.1038/s41591-023-02316-5

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants

Deidre Wilkins, Yuan Yuan, Yue Chang, Anastasia A. Aksyuk, Beatriz Seoane Núñez, Ulrika Wählby Hamrén, Tianhui Zhang, Michael E. Abram, Amanda Leach, Tonya Villafana, Mark T. Esser

Nature Portfolio (2023) • Volume 29, Issue 5, Pages 1172-1179

PDF Available

Quick Actions

Read Full Paper

Publication Info

DOI

10.1038/s41591-023-02316-5

Language

English

Topic

Respiratory viral infections research

Keywords

Antibody, Immune system, Immunology, Medicine, Virus, Respiratory system, Monoclonal antibody, Virology, Pneumovirinae, Palivizumab, Paramyxoviridae, Viral disease, Internal medicine

Published

April 24, 2023

Citations

103 citations

FWCI

36.36

External Resources

DOI Link OpenAlex

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants

Quick Actions

Publication Info

External Resources

Suggested Papers

European guideline for the diagnosis and treatment of insomnia

Influence of Different Intensities of Resistance Training on Selected Strength Parameters among Male Judo Players

Comparison of adult HIV prevalence from national population-based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data

Suggested Papers

Suggested Papers

European guideline for the diagnosis and treatment of insomnia

Influence of Different Intensities of Resistance Training on Selected Strength Parameters among Male Judo Players

Comparison of adult HIV prevalence from national population-based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data